Moderna (Brazil) Analysis

M1RN34 Stock  BRL 12.05  0.04  0.33%   
Moderna is overvalued with Real Value of 11.22 and Hype Value of 12.05. The main objective of Moderna stock analysis is to determine its intrinsic value, which is an estimate of what Moderna is worth, separate from its market price. There are two main types of Moderna's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Moderna's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Moderna's stock to identify patterns and trends that may indicate its future price movements.
The Moderna stock is traded in Brazil on Sao Paulo Exchange, with the market opening at 10:00:00 and closing at 18:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Brazil. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Moderna's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moderna. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.

Moderna Stock Analysis Notes

The book value of the company was now reported as 4.65. The company recorded earning per share (EPS) of 7.47. Moderna had not issued any dividends in recent years. The entity had 1:2 split on the 20th of November 2022. Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts. MODERNA INC operates under Biotechnology classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 1800 people. To find out more about Moderna contact Stephane Bancel at 617 714 6500 or learn more at https://www.modernatx.com.

Moderna Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Moderna's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Moderna or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Moderna generated a negative expected return over the last 90 days
Moderna has high historical volatility and very poor performance

Moderna Market Capitalization

The company currently falls under 'Mega-Cap' category with a current market capitalization of 349.58 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Moderna's market, we take the total number of its shares issued and multiply it by Moderna's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Moderna Profitablity

Moderna's profitability indicators refer to fundamental financial ratios that showcase Moderna's ability to generate income relative to its revenue or operating costs. If, let's say, Moderna is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Moderna's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Moderna's profitability requires more research than a typical breakdown of Moderna's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.55 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.62 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.62.

Technical Drivers

As of the 23rd of December, Moderna secures the Risk Adjusted Performance of (0.14), standard deviation of 3.53, and Mean Deviation of 2.77. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Moderna, as well as the relationship between them.

Moderna Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Moderna middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Moderna. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Moderna Predictive Daily Indicators

Moderna intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Moderna stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Moderna Forecast Models

Moderna's time-series forecasting models are one of many Moderna's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Moderna's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Moderna Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Moderna prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Moderna shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Moderna. By using and applying Moderna Stock analysis, traders can create a robust methodology for identifying Moderna entry and exit points for their positions.
Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts. MODERNA INC operates under Biotechnology classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 1800 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Moderna to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Economic Indicators Now

   

Economic Indicators

Top statistical indicators that provide insights into how an economy is performing
All  Next Launch Module

Complementary Tools for Moderna Stock analysis

When running Moderna's price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Directory
Find actively traded commodities issued by global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity